Bringing the Best to Ohio State
The OSUCCC – James attracts some of the brightest minds in cancer research, and Pelotonia dollars help them continue their research when they arrive. Among those recruited since last year’s investment report are these four prominent senior researchers:
CHERYL TAYLORE LEE, MD, is professor and chair of the College of Medicine’s Department of Urology. An expert in outcomes research and comparative studies, she was recruited from the University of Michigan to lead Ohio State’s urology, uro/gynecology and uro/oncologic programs. As a member of the University of Michigan Comprehensive Cancer Center, she cared primarily for patients with bladder cancer. Having been a principal investigator (PI) or co-PI on numerous clinical trials, Lee focuses her research on strategies to improve patient outcomes and quality of life after surgical treatments.
TIMOTHY PAWLIK, MD, MPH, PHD, is professor and chair of the College of Medicine’s Department of Surgery. Pawlik, a liver cancer expert, came to Ohio State from Johns Hopkins Hospital, where he was chief of the Division of Surgical Oncology, program director of the Surgical Oncology Fellowship and director of the Johns Hopkins Liver Tumor Center. He has authored or co-authored more than 600 published articles and over 50 book chapters, and he has edited five surgical textbooks. His primary interests include alimentary tract surgery with a special interest in hepatic, pancreatic and biliary diseases.
KAREN PATRICIA WILLIAMS, PHD, is a Nursing Distinguished Professor of Women’s Health and director of the Center for Women, Children and Youth at The Ohio State University College of Nursing. She came to Ohio State from Michigan State University. Her research interest is cancer prevention and control, and prevention interventions for disenfranchised women of color.
DEAN LEE, MD, PHD, was recruited from MD Anderson Cancer Center in Houston as director of the Cellular Therapy and Cancer Immunotherapy Program for Nationwide Children’s Hospital’s Division of Hematology/Oncology/BMT and Center for Childhood and Blood Diseases. Lee, who also serves as director of cellular therapy at the OSUCCC – James, specializes in care for children undergoing stem cell transplantation. His research focuses on clinical trials of adoptive immune therapy with natural killer cells.
In addition, Pelotonia dollars have supported the work of 15 mid-level and junior oncology scientists and physicians recruited to Ohio State.